These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15926870)

  • 41. Attenuated peptide YY release in obese subjects is associated with reduced satiety.
    le Roux CW; Batterham RL; Aylwin SJ; Patterson M; Borg CM; Wynne KJ; Kent A; Vincent RP; Gardiner J; Ghatei MA; Bloom SR
    Endocrinology; 2006 Jan; 147(1):3-8. PubMed ID: 16166213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bariatric surgery - time to replace with GLP-1?
    Webb DL; Abrahamsson N; Sundbom M; Hellström PM
    Scand J Gastroenterol; 2017; 52(6-7):635-640. PubMed ID: 28276830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin.
    Chan JL; Stoyneva V; Kelesidis T; Raciti P; Mantzoros CS
    Diabetologia; 2006 Jan; 49(1):169-73. PubMed ID: 16362815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperglycemia abolishes meal-induced satiety by a dysregulation of ghrelin and peptide YY3-36 in healthy overweight/obese humans.
    Knudsen SH; Karstoft K; Solomon TP
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E225-31. PubMed ID: 24302008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gut hormone peptide YY regulates appetite.
    Batterham RL; Bloom SR
    Ann N Y Acad Sci; 2003 Jun; 994():162-8. PubMed ID: 12851312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
    McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
    Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
    Lean ME; Malkova D
    Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
    Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein PYY and its role in metabolism.
    Price SL; Bloom SR
    Front Horm Res; 2014; 42():147-54. PubMed ID: 24732932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity treatment: novel peripheral targets.
    Field BC; Chaudhri OB; Bloom SR
    Br J Clin Pharmacol; 2009 Dec; 68(6):830-43. PubMed ID: 20002077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.
    Nishizawa N; Niida A; Adachi Y; Masuda Y; Kumano S; Yokoyama K; Asakawa T; Hirabayashi H; Amano N; Takekawa S; Ohtaki T; Asami T
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3829-3832. PubMed ID: 28684122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut peptides in the regulation of food intake and energy homeostasis.
    Murphy KG; Dhillo WS; Bloom SR
    Endocr Rev; 2006 Dec; 27(7):719-27. PubMed ID: 17077190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
    Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
    Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PYY transgenic mice are protected against diet-induced and genetic obesity.
    Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.
    Giménez-Palop O; Giménez-Pérez G; Mauricio D; González-Clemente JM; Potau N; Berlanga E; Trallero R; Laferrère B; Caixàs A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):198-204. PubMed ID: 17223988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
    Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
    Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastrointestinal satiety signals.
    Chaudhri OB; Field BC; Bloom SR
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S28-31. PubMed ID: 19136988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.
    Roth CL; Enriori PJ; Harz K; Woelfle J; Cowley MA; Reinehr T
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6386-91. PubMed ID: 16204364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.